134 related articles for article (PubMed ID: 21410641)
21. A common 253-kb deletion involving VWF and TMEM16B in German and Italian patients with severe von Willebrand disease type 3.
Schneppenheim R; Castaman G; Federici AB; Kreuz W; Marschalek R; Oldenburg J; Oyen F; Budde U
J Thromb Haemost; 2007 Apr; 5(4):722-8. PubMed ID: 17371490
[TBL] [Abstract][Full Text] [Related]
22. Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I.
Zhang ZP; Lindstedt M; Falk G; Blombäck M; Egberg N; Anvret M
Am J Hum Genet; 1992 Oct; 51(4):850-8. PubMed ID: 1415226
[TBL] [Abstract][Full Text] [Related]
23. Type 2M:Milwaukee-1 von Willebrand disease: an in-frame deletion in the Cys509-Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets.
Mancuso DJ; Kroner PA; Christopherson PA; Vokac EA; Gill JC; Montgomery RR
Blood; 1996 Oct; 88(7):2559-68. PubMed ID: 8839848
[TBL] [Abstract][Full Text] [Related]
24. Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease.
Piao YC; Lavergne JM; Boyer-Neumann C; Schandelong A; Alessi MC; Meyer D
Blood Coagul Fibrinolysis; 1993 Oct; 4(5):787-9. PubMed ID: 8292729
[TBL] [Abstract][Full Text] [Related]
25. Identification of a new type 2M von Willebrand disease mutation also at position 1324 of von Willebrand factor.
Hilbert L; Fressinaud E; Ribba AS; Meyer D; Mazurier C;
Thromb Haemost; 2002 Apr; 87(4):635-40. PubMed ID: 12008946
[TBL] [Abstract][Full Text] [Related]
26. Substitution of cysteine for phenylalanine 751 in mature von Willebrand factor is a novel candidate mutation in a family with type IIA von Willebrand disease.
Gaucher C; Hanss M; Dechavanne M; Mazurier C
Br J Haematol; 1993 Jan; 83(1):94-9. PubMed ID: 8435341
[TBL] [Abstract][Full Text] [Related]
27. Identification of a new candidate mutation, G1629R, in a family with type 2A von Willebrand disease.
Casaña P; Martínez F; Haya S; Aznar JA
Am J Hematol; 1999 Apr; 60(4):309-10. PubMed ID: 10203106
[TBL] [Abstract][Full Text] [Related]
28. Q1311X: a novel nonsense mutation of putative ancient origin in the von Willebrand factor gene.
Casaña P; Martínez F; Haya S; Lorenzo JI; Espinós C; Aznar JA
Br J Haematol; 2000 Nov; 111(2):552-5. PubMed ID: 11122100
[TBL] [Abstract][Full Text] [Related]
29. Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease.
Ngo KY; Glotz VT; Koziol JA; Lynch DC; Gitschier J; Ranieri P; Ciavarella N; Ruggeri ZM; Zimmerman TS
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2753-7. PubMed ID: 3258663
[TBL] [Abstract][Full Text] [Related]
30. Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor.
Eikenboom JC; Matsushita T; Reitsma PH; Tuley EA; Castaman G; Briët E; Sadler JE
Blood; 1996 Oct; 88(7):2433-41. PubMed ID: 8839833
[TBL] [Abstract][Full Text] [Related]
31. Two new candidate mutations in type IIA von Willebrand's disease (Arg834-->Gly, Gly846-->Arg) and one polymorphism (Tyr821-->Cys) in the A2 region of the von Willebrand factor.
Donnér M; Kristoffersson AC; Berntorp E; Scheibel E; Thorsen S; Dahlbäck B; Nilsson IM; Holmberg L
Eur J Haematol; 1993 Jul; 51(1):38-44. PubMed ID: 8348943
[TBL] [Abstract][Full Text] [Related]
32. Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease.
Gaucher C; Mercier B; Jorieux S; Oufkir D; Mazurier C
Br J Haematol; 1991 Aug; 78(4):506-14. PubMed ID: 1832934
[TBL] [Abstract][Full Text] [Related]
33. A novel family with recessive von Willebrand disease due to compound heterozygosity for a splice site mutation and a missense mutation in the von Willebrand factor gene.
Castaman G; Novella E; Castiglia E; Eikenboom JC; Rodeghiero F
Thromb Res; 2002 Jan; 105(2):135-8. PubMed ID: 11958803
[TBL] [Abstract][Full Text] [Related]
34. A novel mutation (Leu817Pro) causing type 2A von Willebrand disease.
Gemmati D; Serino ML; Moratelli S; Ballerini G; Furbetta M; Lunghi B; Marchetti G; Bernardi F
Br J Haematol; 1996 Jan; 92(1):241-3. PubMed ID: 8562403
[TBL] [Abstract][Full Text] [Related]
35. Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets.
Kroner PA; Kluessendorf ML; Scott JP; Montgomery RR
Blood; 1992 Apr; 79(8):2048-55. PubMed ID: 1373334
[TBL] [Abstract][Full Text] [Related]
36. Discordant von Willebrand factor (VWF) activity in patients with VWF p.Gly1324Ser confirmed in vitro.
Bowman M; Rimmer E; Houston DS; Israels SJ; James P
Haemophilia; 2018 Mar; 24(2):e57-e59. PubMed ID: 29341351
[No Abstract] [Full Text] [Related]
37. [Detection of gene mutation and genetic analysis of a patient with type 3 von Willebrand disease].
Li Z; Wang Y; Wan H
Zhonghua Xue Ye Xue Za Zhi; 1998 Mar; 19(3):122-4. PubMed ID: 11243141
[TBL] [Abstract][Full Text] [Related]
38. [Mutation (Ala737-->Glu) in type 2A von Willebrand disease].
Wang Y; Zhang J; Wan H
Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):117-9. PubMed ID: 11601234
[TBL] [Abstract][Full Text] [Related]
39. von Willebrand disease family studies: comparison of three methods of analysis of the von Willebrand factor gene polymorphism related to a variable number tandem repeat sequence in intron 40.
Gaucher C; Mercier B; Mazurier C
Br J Haematol; 1992 Sep; 82(1):73-80. PubMed ID: 1419805
[TBL] [Abstract][Full Text] [Related]
40. Von Willebrand factor 1 and factor 2 alleles (intron 40) are suitable markers for carrier detection in von Willebrand disease families in the Indian population.
Trasi S; Mohanty D; Pathare A; Shetty S; Ghosh K
Acta Haematol; 2006; 115(1-2):64-7. PubMed ID: 16424652
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
